ECHELON NUTRITIONAL LABORATORIES, LLC – Trademark Portfolio
Entity Type: 16
ECHELON NUTRITIONAL LABORATORIES, LLC holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 32 (Light Beverages) — 2 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include VAMONOS and ENERGY AMIGO. The owner is based in PROVO, UT.
878 North 1200 East
PROVO, UT 84604
Showing of trademarks Trademarks
Trademark Classifications
ECHELON NUTRITIONAL LABORATORIES, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does ECHELON NUTRITIONAL LABORATORIES, LLC have?
ECHELON NUTRITIONAL LABORATORIES, LLC has 4 U.S. trademarks filed with the USPTO. Of these, 4 registered.
What trademark classes does ECHELON NUTRITIONAL LABORATORIES, LLC file in?
ECHELON NUTRITIONAL LABORATORIES, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 32 (Light Beverages), Class 5 (Pharmaceuticals). Class 32 covers beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages.
What are ECHELON NUTRITIONAL LABORATORIES, LLC's most well-known trademarks?
ECHELON NUTRITIONAL LABORATORIES, LLC's registered trademark portfolio includes well-known marks such as VAMONOS and ENERGY AMIGO. These are among 4 currently registered trademarks in the portfolio.
What is ECHELON NUTRITIONAL LABORATORIES, LLC's trademark registration success rate?
ECHELON NUTRITIONAL LABORATORIES, LLC has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.